Safety study of a new investigational drug in healthy volunteers
Part of Lungs & breathing clinical trials.
This trial tests a new medicine to see how the body handles it and whether it is safe. It is for healthy people, not for treating a disease, and helps researchers decide if the drug can move to the next stage of testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are generally healthy, with no serious medical conditions.
- You weigh at least 110 pounds (50 kg) if you are a man, or at least 99 pounds (45 kg) if you are a woman.
- Your body mass index (BMI) is between 18 and 32.
- You are a man, or a woman who cannot become pregnant (e.g., surgically sterile or past menopause).
- You have not had a serious infection (like pneumonia or shingles) in the past 3 months, and you do not have chronic infections.
- You do not have a history of certain cancers (like lymphoma or breast cancer) within the past 5 to 10 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication (GSK5784283) for people with moderate to severe COPD who have a certain type of inflammation (eosinophilic). Participants must be on standard inhaler therapy and have a history of smoking. The trial will compare the new drug to a placebo.
This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This study tests an experimental medication for chronic obstructive pulmonary disease (COPD) in two parts: first in healthy volunteers, then in people with COPD. It aims to see if the drug is safe and how well it works.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
Hear when a new Pulmonary Disease, Chronic Obstructive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.